Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Fycompa
Active Ingredient: Perampanel hemisesquihydrate 2.1mg equivalent to perampanel 2mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Eisai New Zealand Limited
Manufacturers: Eisai Co Limited, Kakamigahara-shi, Japan
Eisai Manufacturing Limited, Hatfield, United Kingdom
   
Product: Fycompa
Active Ingredient: Perampanel hemisesquihydrate 4.2mg equivalent to perampanel 4mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Eisai New Zealand Limited
Manufacturers: Eisai Co Limited, Kakamigahara-shi, Japan
Eisai Manufacturing Limited, Hatfield, United Kingdom
   
Product: Fycompa
Active Ingredient: Perampanel hemisesquihydrate 6.2mg equivalent to perampanel 6mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Eisai New Zealand Limited
Manufacturers: Eisai Co Limited, Kakamigahara-shi, Japan
Eisai Manufacturing Limited, Hatfield, United Kingdom
   
Product: Fycompa
Active Ingredient: Perampanel hemisesquihydrate 8.3mg equivalent to perampanel 8mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Eisai New Zealand Limited
Manufacturers: Eisai Co Limited, Kakamigahara-shi, Japan
Eisai Manufacturing Limited, Hatfield, United Kingdom
   
Product: Fycompa
Active Ingredient: Perampanel hemisesquihydrate 10.4mg equivalent to perampanel 10mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Eisai New Zealand Limited
Manufacturers: Eisai Co Limited, Kakamigahara-shi, Japan
Eisai Manufacturing Limited, Hatfield, United Kingdom
   
Product: Fycompa
Active Ingredient: Perampanel hemisesquihydrate 12.5mg equivalent to perampanel 12mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Eisai New Zealand Limited
Manufacturers: Eisai Co Limited, Kakamigahara-shi, Japan
Eisai Manufacturing Limited, Hatfield, United Kingdom
   
Product: Mylan Fentanyl Patch
Active Ingredient: Fentanyl 1.28mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Viatris Limited
Manufacturer: Mylan Technologies, Vermont, United States of America
   
Product: Mylan Fentanyl Patch
Active Ingredient: Fentanyl 2.55mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Viatris Limited
Manufacturer: Mylan Technologies, Vermont, United States of America
   
Product: Mylan Fentanyl Patch
Active Ingredient: Fentanyl 5.1mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Viatris Limited
Manufacturer: Mylan Technologies, Vermont, United States of America
   
Product: Mylan Fentanyl Patch
Active Ingredient: Fentanyl 7.65mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Viatris Limited
Manufacturer: Mylan Technologies, Vermont, United States of America
   
Product: Mylan Fentanyl Patch
Active Ingredient: Fentanyl 10.2mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Viatris Limited
Manufacturer: Mylan Technologies, Vermont, United States of America
   
Product: Nicorette Cooldrops
Active Ingredient: Nicotine polacrilex 10mg equivalent to nicotine 2mg
Dosage Form: Lozenge
New Zealand Sponsor: Johnson & Johnson (New Zealand) Limited
Manufacturer: McNeil AB, Helsingborg, Sweden
   
Product: Nicorette Cooldrops
Active Ingredient: Nicotine polacrilex 20mg equivalent to nicotine 4mg
Dosage Form: Lozenge
New Zealand Sponsor: Johnson & Johnson (New Zealand) Limited
Manufacturer: McNeil AB, Helsingborg, Sweden
   
Product: Optrex Eye Drops
Active Ingredient: Naphazoline hydrochloride 0.01%w/v
Dosage Form: Eye drops, solution
New Zealand Sponsor: Reckitt Benckiser (New Zealand) Limited
Manufacturer: Reckitt Benckiser Healthcare International Limited, Nottingham, United Kingdom


Dated this 22nd day of April 2022.

DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).